Past Medical Applied sciences Inc. is happy to announce that additional to its information launch dated January 14, 2021 saying its letter of intent with Kayan Well being Restricted, Kayan Well being has launched a Digital Medical ‘Second Opinion’ platform as a part of its suite of digital well being merchandise.
Past Medical Applied sciences Inc. (“Past Medical” or the “Firm”) (CSE: DOCT) (Frankfurt: 7FM3), is happy to announce that additional to its information launch dated January 14, 2021 saying its letter of intent with Kayan Well being Restricted (“Kayan Well being”), Kayan Well being has launched a Digital Medical ‘Second Opinion’ platform (the “Second Opinion Platform”) as a part of its suite of digital well being merchandise.
The Second Opinion Platform can be a peer-to-peer service that can match clinicians within the Caribbean with clinicians in america to overview affected person medical information. Physicians situated within the Caribbean will be capable to submit medical information, scans, and reply questions posed by clinicians in america, who will then present a second opinion, which is able to lead to sufferers within the Caribbean with the ability to make a extra knowledgeable choice with respect to their prognosis or proposed remedy.
The Second Opinion Platform can be executed in collaboration with considered one of Kayan Well being’s strategic companions, Black Pearl World Investments. Through the first part of the Second Opinion Platform, three scientific specialties can be obtainable:
Pulmonary Medication;
Acute Vital Care/Emergency Intensive Care; and
Psychological Well being.
Kayan Well being believes the Second Opinion Platform will fill the void left within the medical tourism market as many sufferers should not in a position to journey because of COVID-19.
About Kayan Well being
Kayan Well being’s proprietary AI-powered well being communications platform helps docs streamline communications with their sufferers and remotely monitor them. Moreover, Kayan Well being’s proprietary platform permits sufferers to schedule digital consultations with their physicians and talk with them by means of chat, audio and video calls. The platform additionally integrates with wearable gadgets and diagnostic instruments that delivers each sufferers and docs with larger visibility into the affected person’s well being and supplies them with proactive automated alerts comparable to elevated blood strain and coronary heart charges. Storing all this knowledge in a holistic affected person profile that’s built-in with the clinic’s digital well being techniques – making certain their sufferers’ well being information are updated, accessible by all, helps ship higher care and permits clinics to generate extra income.
Kayan Well being’s platform has already been deployed in a number of clinics in america and is projected to achieve $5M in income by 2022. Kayan Well being’s proprietary platform was developed by the founders of HeyDoc!, a telehealth app launched in 2016 that had supported over 3,000 sufferers globally. Kayan Well being is a privately held firm based mostly in Toronto, Ontario.
Non-public Placement
Moreover, the Firm declares that it has amended the phrases of its beforehand introduced non-public placement (the “Non-public Placement”) of models (the “Items”), lowering the issuance worth of the Items from $0.15 per Unit to $0.125 per Unit. Every Unit will nonetheless consist of 1 widespread share within the capital of the Firm (a “Share”) and one Share buy warrant (a “Warrant”). Every Warrant can be exercisable to buy one extra Share (every, a “Warrant Share”) at a worth of $0.20 per Warrant Share, against the beforehand introduced $0.30, for a interval of two (2) years from closing of the Non-public Placement (the “Closing Date”).
The Warrants can be topic to an acceleration proper of the Firm (the “Warrant Acceleration Proper”) if on any ten (10) consecutive buying and selling days the closing worth of the Shares is bigger than $0.40 per Share. If the Firm workout routines its Warrant Acceleration Proper, the brand new expiry date of the Warrants would be the thirtieth day following the discover to Warrant holders of such train.
The Non-public Placement is topic to various situations, together with receipt of all mandatory company and regulatory approvals, together with the approvals of the Canadian Securities Alternate (the “CSE”).
All securities issued in reference to the Non-public Placement can be topic to a statutory maintain interval of 4 months plus a day from the date of issuance in accordance with relevant securities legal guidelines. A finder’s payment could also be paid in reference to the Non-public Placement to eligible arm’s size finders in accordance with CSE insurance policies and relevant securities legal guidelines.
The securities supplied haven’t been and won’t be registered below america Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities legal guidelines and is probably not supplied or offered absent registration or compliance with an relevant exemption from the registration necessities of the U.S. Securities Act and relevant state securities legal guidelines.
About Past Medical
Past Medical is an industrial/know-how firm with a producing facility situated in Delta, British Columbia. The Firm is growing its Organivore and Pharmavore waste digesters utilizing its proprietary know-how. The Firm, by means of its subsidiary Micron Applied sciences, can also be manufacturing medical grade facemasks compliant with ASTM F2100 Requirements.
The Canadian Inventory Alternate, nor its regulation service supplier, settle for duty for the adequacy or accuracy of this information launch.
FORWARD LOOKING STATEMENTS:
All info contained on this information launch with respect to the Firm and Kayan Well being was provided by the events, respectively, for inclusion herein, and the Firm and its respective administrators and officers have relied on Kayan Well being for any info regarding such occasion.
This information launch doesn’t represent a suggestion to promote or a solicitation of a suggestion to promote any of the securities in america. The securities haven’t been and won’t be registered below the U.S. Securities Act or any state securities legal guidelines and is probably not supplied or offered inside america or to U.S. Individuals except registered below the U.S. Securities Act and relevant state securities legal guidelines or an exemption from such registration is accessible.
This launch contains sure statements that could be deemed “forward-looking statements”. All statements on this launch, apart from statements of historic information, that handle occasions or developments that the Firm expects to happen, are forward-looking statements. Ahead-looking statements are statements that aren’t historic information and are usually, however not at all times, recognized by the phrases “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “initiatives”, “potential” and related expressions, or that occasions or situations “will”, “would”, “might”, “may” or “ought to” happen. Though the Firm believes the expectations expressed in such forward-looking statements are based mostly on cheap assumptions, such statements should not ensures of future efficiency and precise outcomes might differ materially from these within the forward-looking statements. Elements that might trigger the precise outcomes to vary materially from these in forward-looking statements embrace market costs, continued availability of capital and financing, and normal financial, market or enterprise situations. Traders are cautioned that any such statements should not ensures of future efficiency and precise outcomes or developments might differ materially from these projected within the forward-looking statements. Ahead-looking statements are based mostly on the beliefs, estimates and opinions of the Firm’s administration on the date the statements are made. Besides as required by relevant securities legal guidelines, the Firm undertakes no obligation to replace these forward-looking statements within the occasion that administration’s beliefs, estimates or opinions, or different components, ought to change.
For additional info: Kal Malhi, CEO, 604-805-4602, kal@bullruncapital.ca
